These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8904176)

  • 1. Plasma factor VIIa: measurement and potential clinical significance.
    Morrissey JH
    Haemostasis; 1996; 26 Suppl 1():66-71. PubMed ID: 8904176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
    Morrissey JH; Macik BG; Neuenschwander PF; Comp PC
    Blood; 1993 Feb; 81(3):734-44. PubMed ID: 8427965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
    Kario K; Miyata T; Sakata T; Matsuo T; Kato H
    Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The various assays for measuring activity states of factor VIIa in plasma and therapeutic products: Diagnostic value and analytical usefulness in various pathophysiological states.
    Amiral J; Dunois C; Amiral C; Seghatchian J
    Transfus Apher Sci; 2017 Feb; 56(1):91-97. PubMed ID: 28089408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.
    Spiezia L; Campello E; Valle FD; Woodhams B; Simioni P
    Clin Chem Lab Med; 2017 Mar; 55(4):484-488. PubMed ID: 27522621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.
    Olson NC; Raffield LM; Lange LA; Lange EM; Longstreth WT; Chauhan G; Debette S; Seshadri S; Reiner AP; Tracy RP
    J Thromb Haemost; 2018 Jan; 16(1):19-30. PubMed ID: 29112333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
    Morrissey JH
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S14-9. PubMed ID: 7647216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study Group.
    Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
    Vox Sang; 1997; 73(3):155-61. PubMed ID: 9358617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease].
    Kario K; Matsuo T; Miyata T
    Rinsho Byori; 1995 Dec; 43(12):1201-8. PubMed ID: 8569029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
    Lwaleed BA; Goyal A; Delves G; Gossai S; Greenfield RS; Cooper AJ
    Int J Androl; 2007 Dec; 30(6):543-9. PubMed ID: 17459125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
    Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
    Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of activated FVII in various diseases.
    Yamada A; Wada H; Kamikura Y; Hiyoyama K; Shimura M; Nagaya S; Deguchi K; Mori Y; Shiku H
    Blood Coagul Fibrinolysis; 1996 Nov; 7(8):794-8. PubMed ID: 9034561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor modulation of factor VIIa activity: use in measuring trace levels of factor VIIa in plasma.
    Morrissey JH
    Thromb Haemost; 1995 Jul; 74(1):185-8. PubMed ID: 8578455
    [No Abstract]   [Full Text] [Related]  

  • 15. Age- and sex-related differences of plasma activated factor VII levels in children.
    Sakata T; Yamamura T; Kario K; Katayama Y; Matsuyama T; Kato H; Yamamoto A; Miyata T
    Thromb Haemost; 1999 Jun; 81(6):910-2. PubMed ID: 10404766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel specific immunoassay for plasma two-chain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes.
    Philippou H; Adami A; Amersey RA; Stubbs PJ; Lane DA
    Blood; 1997 Feb; 89(3):767-75. PubMed ID: 9028306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased plasma levels of activated factor VII in patients with deep vein thrombosis.
    Schut AM; Meijers JC; Lisman-van Leeuwen Y; van Montfoort ML; Roest M; de Groot PG; Urbanus RT; Coppens M; Lisman T
    J Thromb Haemost; 2015 Jul; 13(7):1320-4. PubMed ID: 25891834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
    Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIIa in patients with C1-inhibitor deficiency.
    Nielsen EW; Morrissey J; Olsen JO; Osterud B
    Thromb Haemost; 1995 Oct; 74(4):1103-6. PubMed ID: 8560420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.